SOURCE: InoLife Technologies, Inc.

November 04, 2014 09:15 ET

INOL Announces New Product Line Under the Brand of Kumi

RALEIGH, NC--(Marketwired - Nov 4, 2014) - InoLife Technologies, Inc. (PINKSHEETS: INOL) announced the roll out of a new line of products which will be under the brand name of Kumi. This line of products will be in the multi-billion dollar skin care and anti-aging industry. The products are produced and developed through a strategic alliance with an ISO 9001:2008 & ISO 14001(2004) accredited pharmaceutical company and WHO GMP certified for all its products and is specialized in the manufacturing of Cephalosporins and its intermediates. It has a wide range of products and is fast expanding to meet the present and future market demands for the high value drugs. It manufactures the Active Pharmaceutical Ingredient (API) in bulk quantities for both Indian and international regulated and semi-regulated markets. All the drugs manufactured meet USP / BP / JP standards.

InoLife is pleased to develop and offer a brand of products under the Kumi label. In the coming days INOL will launch www.kumiproducts.com and begin sales of their first product in the Kumi line.

InoLife CEO Gary Berthold stated, "We are proud to escalate our product development to bring to market some of the finest products in the anti-aging skin care industry. Our relationship will provide a unique opportunity for a dramatic growth in this dynamic industry."

In the coming weeks InoLife Technologies will be releasing information of the first product in the Kumi line.

InoLife Technologies, Inc. markets the commercial use of proprietary Intellectual Property by manufacturing, brand marketing and selling an integrated program of age reversing creams and lotions. These products will be sold directly to consumers through e-commerce, direct sales, pharmacies, retailers, distributors and healthcare providers. It also offers products that are sold only to physicians, hospitals, outpatient facilities and others in the medical community for use with their patients.

Forward-Looking Statements: Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.

Contact Information